Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 30, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | (Q2)Aug 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.67%40.36B | 9.21%41.81B | 7.27%156.35B | 9.78%38.94B | 4.96%38.18B | 4.59%38.29B | 23.27%145.76B | 9.04%37.31B | 19.76%35.47B | 29.16%36.38B |
| Cost of revenue | 5.95%11.94B | 12.46%12.26B | 7.32%45B | 10.19%11.27B | 3.42%10.84B | 3.73%10.9B | 26.19%41.93B | 11.69%10.71B | 22.96%10.23B | 32.62%10.48B |
| Gross profit | 2.74%28.42B | 7.92%29.55B | 7.25%111.35B | 9.62%27.66B | 5.59%27.34B | 4.93%27.38B | 22.14%103.83B | 8.01%26.6B | 18.51%25.24B | 27.81%25.89B |
| Operating expense | 5.43%26.76B | 7.60%26.5B | 6.30%102.85B | 7.38%25.38B | 2.16%25.25B | 6.55%24.63B | 21.05%96.75B | 0.25%25.29B | 14.16%23.63B | 21.51%24.71B |
| Selling and administrative expenses | 3.92%26.33B | 8.33%26.2B | 7.38%101.13B | 8.40%25.33B | 5.81%25.15B | 6.02%24.18B | 13.29%94.18B | 2.70%24.23B | 14.96%23.37B | 16.42%23.77B |
| -General and administrative expense | 3.92%26.33B | 8.33%26.2B | 7.38%101.13B | 8.40%25.33B | 5.81%25.15B | 6.02%24.18B | 13.29%94.18B | 2.70%24.23B | 14.96%23.37B | 16.42%23.77B |
| Other operating expenses | 117.56%570M | -23.44%490M | -21.63%2.62B | -42.42%262M | -74.43%291M | 18.96%640M | -12.88%3.35B | -38.55%1.22B | -44.17%455M | 94.53%1.14B |
| Total other operating income | -35.32%141M | -4.71%182M | 16.56%901M | 12.95%218M | 0.00%194M | -17.32%191M | -89.03%773M | -54.97%154M | -56.43%193M | -70.78%194M |
| Operating profit | -27.11%1.67B | 10.79%3.05B | 20.18%8.5B | 42.67%2.29B | 77.61%2.09B | -7.62%2.75B | 39.21%7.08B | 319.03%1.31B | 169.87%1.6B | 1,573.75%1.18B |
| Net non-operating interest income (expenses) | 47.86%-73M | 66.67%-56M | -90.52%-844M | 6.67%-140M | -45.20%-257M | -200.00%-168M | 14.48%-443M | 76.74%-60M | 24.62%-150M | -608.00%-177M |
| Non-operating interest income | -15.63%81M | 139.39%237M | -75.91%53M | 405.26%96M | -16.28%72M | 12.50%99M | 2.33%220M | 273.68%66M | --19M | -32.28%86M |
| Non-operating interest expense | -34.75%154M | 9.74%293M | 35.29%897M | 39.64%236M | 25.10%329M | 85.42%267M | -9.55%663M | -42.73%126M | -15.08%169M | 73.03%263M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -25.71%1.6B | 15.79%2.99B | 15.49%7.66B | 47.76%2.15B | 83.42%1.84B | -11.63%2.58B | 45.28%6.63B | 246.38%1.25B | 268.78%1.45B | 1,071.84%1B |
| Income tax | -15.22%401M | 35.32%728M | 39.88%1.43B | -9.56%473M | 308.70%376M | -4.44%538M | 49.13%1.02B | 70.57%-156M | 537.80%523M | 174.80%92M |
| Net income | -28.67%1.19B | 10.61%2.26B | 11.06%6.23B | 80.19%1.67B | 60.62%1.46B | -13.31%2.05B | 44.61%5.61B | 532.21%1.41B | 197.76%929M | 4,684.21%909M |
| Net income continuous operations | -28.67%1.19B | 10.65%2.26B | 11.04%6.23B | 80.00%1.67B | 60.62%1.46B | -13.34%2.05B | 44.60%5.61B | 532.21%1.41B | 198.08%930M | 4,445.00%909M |
| Noncontrolling interests | -40.46%78M | -9.33%175M | 12.35%637M | 98.48%131M | 445.45%120M | -7.66%193M | 15.01%567M | 258.67%269M | 78.38%66M | 131.88%22M |
| Net income attributable to the company | -27.63%1.12B | 12.74%2.09B | 10.89%5.59B | 78.68%1.54B | 51.07%1.34B | -13.86%1.85B | 48.92%5.04B | 384.29%1.14B | 213.82%863M | 907.95%887M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -27.63%1.12B | 12.74%2.09B | 10.89%5.59B | 78.68%1.54B | 51.07%1.34B | -13.86%1.85B | 48.92%5.04B | 384.29%1.14B | 213.82%863M | 907.95%887M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -27.42%2.66 | 12.60%4.96 | 10.85%13.285 | 78.78%3.665 | 50.95%3.185 | -13.88%4.405 | 48.79%11.985 | 385.26%2.71 | 212.98%2.05 | 904.76%2.11 |
| Diluted earnings per share | -27.69%2.65 | 12.60%4.96 | 10.85%13.285 | 78.78%3.665 | 50.95%3.185 | -13.88%4.405 | 48.79%11.985 | 384.12%2.71 | 212.98%2.05 | 904.76%2.11 |
| Dividend per share | 0 | 0 | 14.29%4 | 0 | 14.29%2 | 0 | 16.67%3.5 | 16.67%1.75 | 0 | 16.67%1.75 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |